Leg­end Biotech looks to raise ad­di­tion­al $350M in stock sale; Acasti com­mits to lay­offs

CAR-T out­fit Leg­end Biotech is look­ing to add more cash to its cof­fers.

On Mon­day morn­ing, Leg­end an­nounced it is sell­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.